Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Achilles Therapeutics Plc
(NQ:
ACHL
)
0.7838
+0.0027 (+0.35%)
Streaming Delayed Price
Updated: 3:57 PM EDT, Apr 24, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
119,428
Open
0.7742
Bid (Size)
0.7633 (20)
Ask (Size)
0.8288 (13)
Prev. Close
0.7811
Today's Range
0.7633 - 0.8090
52wk Range
0.7402 - 1.760
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Dow Dips Over 200 Points; RPM International Shares Fall After Q3 Results
April 04, 2024
U.S. stocks turned lower toward the end of trading, with the Dow Jones index falling more than 200 points on Thursday. The Dow traded down 0.59% to 38,894.58 while the NASDAQ fell 0.10% to 16,261.88....
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why STAAR Surgical Shares Are Trading Higher By Around 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
April 04, 2024
Shares of STAAR Surgical Company (NASDAQ: STAA) rose sharply during Thursday’s session after the company issued strong preliminary first-quarter net sales guidance. STAAR Surgical shares jumped 13.3%...
Via
Benzinga
Performance
YTD
-10.11%
-10.11%
1 Month
-36.28%
-36.28%
3 Month
-12.91%
-12.91%
6 Month
-11.74%
-11.74%
1 Year
-7.79%
-7.79%
More News
Read More
12 Health Care Stocks Moving In Thursday's Intraday Session
April 04, 2024
Via
Benzinga
Achilles Therapeutics: Q1 Earnings Insights
May 10, 2023
Via
Benzinga
Nasdaq Surges 1%; ConAgra Brands Posts Upbeat Earnings
April 04, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
ACHL Stock Earnings: Achilles Therapeutics Misses EPS for Q4 2023
April 04, 2024
Via
InvestorPlace
12 Health Care Stocks Moving In Thursday's Pre-Market Session
April 04, 2024
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
April 04, 2024
Via
InvestorPlace
Achilles Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results and Recent Business Highlights
April 04, 2024
From
Achilles Therapeutics PLC
Via
GlobeNewswire
Achilles Therapeutics Provides Interim Phase I/IIa Update on Clonal Neoantigen Reactive T Cells in Advanced NSCLC and Melanoma Including First Patients Dosed with Enhanced Host Conditioning
April 04, 2024
From
Achilles Therapeutics PLC
Via
GlobeNewswire
Achilles Therapeutics to Present at the 10th Annual Immuno-Oncology 360 Conference
February 05, 2024
From
Achilles Therapeutics PLC
Via
GlobeNewswire
Achilles Therapeutics Announces Publication of Nature Cancer ‘Comment’ on Strategy for Improved Neoantigen Immunogenicity Prediction
December 18, 2023
From
Achilles Therapeutics PLC
Via
GlobeNewswire
Achilles Therapeutics Reports Third Quarter 2023 Financial Results and Recent Highlights
November 13, 2023
From
Achilles Therapeutics PLC
Via
GlobeNewswire
10 Biotech Stocks Below Cash Value with Key Catalysts on the Horizon: An Analysis
October 23, 2023
Via
ACCESSWIRE
Pathways to Progress: How Orphan Drug Designation Sparks Biotech Transformation
September 20, 2023
Via
Investor Brand Network
Exposures
Product Safety
Pathways to Progress: How Orphan Drug Designation Sparks Biotech Transformation
September 20, 2023
Via
FinancialNewsMedia
Exposures
Product Safety
12 Health Care Stocks Moving In Thursday's After-Market Session
September 07, 2023
Via
Benzinga
Achilles Therapeutics Reports Second Quarter 2023 Financial Results and Recent Business Highlights
August 04, 2023
From
Achilles Therapeutics PLC
Via
GlobeNewswire
Achilles Therapeutics to Present at Upcoming Conferences
June 12, 2023
From
Achilles Therapeutics PLC
Via
GlobeNewswire
3 Stocks With 1,000% Upside Potential
May 21, 2023
Via
InvestorPlace
Achilles Therapeutics Reports First Quarter 2023 Financial Results and Recent Business Highlights
May 10, 2023
From
Achilles Therapeutics PLC
Via
GlobeNewswire
Achilles Therapeutics’ New Immunogenicity Prediction Application of its AI-Powered PELEUS™ Platform Uniquely Identifies the Most Potent T Cell Antigens
May 10, 2023
From
Achilles Therapeutics PLC
Via
GlobeNewswire
Achilles Therapeutics Receives Nasdaq Deficiency Notice Regarding Minimum Bid Price Requirement
April 25, 2023
From
Achilles Therapeutics PLC
Via
GlobeNewswire
Achilles Therapeutics Announces Grant of US Patent Covering the Treatment of Patients with an Immunotherapy Targeting Neoantigens Based on Tumor HLA Status
April 25, 2023
From
Achilles Therapeutics PLC
Via
GlobeNewswire
Achilles Therapeutics to Present at Chardan’s 7th Annual Genetic Medicines and Cell Therapy Manufacturing Summit
April 17, 2023
From
Achilles Therapeutics PLC
Via
GlobeNewswire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.